安杰思收盘下跌2.02%，滚动市盈率21.57倍，总市值64.04亿元

Core Insights - The company Anjiasi closed at 79.08 yuan on July 30, with a decline of 2.02%, resulting in a rolling PE ratio of 21.57 times and a total market capitalization of 6.404 billion yuan [1] - In comparison to the medical device industry, which has an average PE ratio of 55.15 times and a median of 37.48 times, Anjiasi ranks 46th [1] - As of the first quarter of 2025, four institutions held shares in Anjiasi, with a total of 87,500 shares valued at 0.06 million yuan [1] Company Overview - Anjiasi Medical Technology Co., Ltd. specializes in the research, development, production, and sales of minimally invasive diagnostic and therapeutic instruments, primarily focusing on GI, EMR/ESD, and ERCP diagnostic series and equipment [1] - The company received seven significant government honors during the reporting period, including recognition as a "Zhejiang Provincial Enterprise Technology Center" and "Zhejiang Provincial High-Growth Biopharmaceutical Enterprise" [1] Financial Performance - In the first quarter of 2025, the company reported revenue of 129 million yuan, representing a year-on-year increase of 15.27%, and a net profit of 56.248 million yuan, reflecting a year-on-year growth of 6.57% [1] - The sales gross margin stood at 70.68% [1]